Unihealth Hospitals MD, chairman, board of directors and AGM
NSE: UNIHEALTHHealthcare Services
Share price at the NSE close on 23 Oct 2026. Previous close ₹475.15.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹850 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 2 Jul 2026
- 32.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 2 Jul 2026
- 21.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 2 Jul 2026
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 2 Jul 2026
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 18,50089.2% delivered
Unihealth Hospitals board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Statutory auditor
Named in the results for the quarter to Mar 2025.
- G P Kapadia & CoPeer-review certificate valid to Jan 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Unihealth Hospitals AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Unihealth Hospitals share news and announcements
Annual general meeting, 28 Jul 2026
1,229 shareholders on the register on 21 Jul 2026; present: 5 promoters and 12 others; votes counted by Ms. Shalini Bhat / Parikh and Associates.The company's voting result (opens in a new tab)
To receive, consider and adopt: a.the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon; and b.the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- To appoint a director in place of Dr. Akshay M. Parmar (DIN 01533004) who retires by rotation and being eligible offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- Appointment of Mr. Bachh Raj Nahar (DIN: 00049895) as Independent Director of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- Revision in Remuneration of Dr. Akshay M. Parmar, Chairman & Managing Director of the companySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- Revision in remuneration of Mr. Parag Shah Executive Director & Chief Financial Officer (CFO) of the companySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- Increase in the Authorized Share Capital of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- Issuance of Equity Shares of the company on Preferential Basis for Consideration other than CashSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.85% · promoters 98.76% · institutions 0.00% · other public 9.47%
- Material Related Party Transaction(s) with UMC Hospitals Private LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 2.80% · promoters 0.00% · institutions 0.00% · other public 9.47%
- Material Related Party Transaction (s) with Victoria Hospital Limited, UgandaOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 2.80% · promoters 0.00% · institutions 0.00% · other public 9.47%
- Material Related Party Transaction(s) with Unihealth Tanzania LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 2.80% · promoters 0.00% · institutions 0.00% · other public 9.47%
- Material Related Party Transaction(s) between Unihealth Holdings Limited (UHL), a wholly owned subsidiary and Unihealth Tanzania Limited, subsidiary of Unihealth Hospitals LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 2.80% · promoters 0.00% · institutions 0.00% · other public 9.47%
- Material Related Party Transaction(s) between Unihealth Pharmaceuticals Private Limited (UPPL), a wholly owned subsidiary and Unihealth (U) Limited, associate Company of Unihealth Hospitals LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 2.80% · promoters 0.00% · institutions 0.00% · other public 9.47%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Tax disputes
Reported in the filing for the quarter to Jun 2026.
- Tax disputeIncome TaxSince 16 Sep 2021Awaiting Order from the CIT
- Tax disputeIncome TaxSince 26 Aug 2024The appeal of the assessee is allowed for statistical purpose, order pronounced in the open court on 29/01/2025. Copy of the order received on 08/05/2025At the filing before: Received Order from the ITAT
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far. A statement's amounts are left out where the raise it states and its own uses differ by fifty times or more, a figure typed at the wrong scale.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesSep 2023 | – | Investment in our joint venture, Victoria Hospital Limited (VHL), Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements of VHL | – | – | No |
| Public IssuesSep 2023 | – | Investment in our joint venture, UMC Global Health Limited (UMCGHL), Nigeria for funding its capital expenditure requirements for proposed expansion | – | – | No |
| Public IssuesSep 2023 | – | Investment in our subsidiary, Biohealth Limited (BL), Tanzania for funding its capital expenditure requirements for proposed expansion | – | – | No |
| Public IssuesSep 2023 | – | NA | – | – | No |
| Public IssuesSep 2023 | – | General Corporate Purpose | – | – | No |
| Public IssuesSep 2023 | – | Issue Expenses | – | – | No |
| Preferential IssuesMay 2025 | – | Funding to its Subsidiary , UMC Hospitals Private Limited to support Capital Expenditures (CAPEX) and working capital requirement for the hospital in India. | – | – | No |
| Preferential IssuesMay 2025 | – | General Corporate Purpose, which includes, without limitation, strategic initiatives, funding growth opportunities, strengthening marketing capabilities and brand building exercises, meeting ongoing general corporate contingencies, fund raising expense and other expenses incurred in ordinary course of business | – | – | No |